| Breakdown | TTM | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 554.53M | 436.21M | 244.59M | 211.00M | 62.24M | 35.16M |
| Gross Profit | 175.77M | 116.15M | 51.41M | 18.99M | -1.89M | -11.82M |
| EBITDA | -190.39M | -151.80M | -144.93M | -95.20M | -91.20M | -45.61M |
| Net Income | -197.63M | -190.18M | -182.57M | -135.94M | -117.32M | -55.01M |
Balance Sheet | ||||||
| Total Assets | 2.22B | 1.18B | 941.21M | 989.12M | 980.85M | 187.87M |
| Cash, Cash Equivalents and Short-Term Investments | 976.74M | 418.99M | 244.77M | 471.79M | 690.96M | 52.79M |
| Total Debt | 516.62M | 468.42M | 176.69M | 152.78M | 128.43M | 27.30M |
| Total Liabilities | 940.41M | 801.89M | 386.67M | 315.92M | 282.40M | 354.58M |
| Stockholders Equity | 1.28B | 382.45M | 554.54M | 673.21M | 698.45M | -166.71M |
Cash Flow | ||||||
| Free Cash Flow | -231.56M | -115.98M | -153.57M | -148.95M | -97.49M | -52.88M |
| Operating Cash Flow | -103.38M | -48.89M | -98.87M | -106.54M | -71.79M | -27.76M |
| Investing Cash Flow | -261.18M | -98.33M | 12.02M | -346.08M | -92.13M | -37.33M |
| Financing Cash Flow | 881.92M | 256.68M | 7.37M | 2.04M | 799.94M | 21.48M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
64 Neutral | $8.32B | -53.60 | -31.83% | ― | 16.89% | -4.41% | |
63 Neutral | $10.79B | 15.43 | 7.44% | 2.01% | 2.89% | -14.66% | |
58 Neutral | $1.94B | -3.42 | -50.08% | ― | -0.63% | -163.11% | |
56 Neutral | $42.77B | -191.26 | -23.24% | ― | 52.42% | -1.33% | |
56 Neutral | $3.42B | -9.55 | ― | ― | 8.07% | 33.37% | |
49 Neutral | $1.37B | ― | -115.63% | ― | ― | -33.69% |
On January 21, 2026, Rocket Lab reported that qualification testing of the Stage 1 tank for its in-development Neutron medium-lift rocket resulted in a rupture during a hydrostatic pressure trial, an event the company framed as a not-uncommon outcome of pushing hardware beyond operating limits in order to validate structural integrity and safety margins. Rocket Lab said there was no significant damage to test structures or facilities, the next Stage 1 tank is already in production, and the broader Neutron development campaign is continuing while engineers review test data to determine the impact on the rocket’s launch schedule, with investors and customers awaiting further clarity on timing at the company’s upcoming fourth-quarter 2025 earnings update in February.
The most recent analyst rating on (RKLB) stock is a Buy with a $120.00 price target. To see the full list of analyst forecasts on Rocket Lab USA stock, see the RKLB Stock Forecast page.
On December 19, 2025, Rocket Lab announced it had secured an $816 million prime contract from the U.S. Space Development Agency to design, manufacture, operate and sustain 18 missile-defense satellites for the Tracking Layer Tranche 3 constellation, with work starting immediately and final satellite delivery expected in 2029. The award, which follows a prior $515 million SDA contract and can expand toward $1 billion when including additional subsystem sales to other Tranche 3 primes, marks Rocket Lab’s largest contract to date and reinforces its emergence as a vertically integrated, disruptive prime contractor in U.S. national security space, challenging legacy aerospace players and deepening its role in the U.S. Space Force’s missile warning and tracking architecture.
The most recent analyst rating on (RKLB) stock is a Hold with a $49.00 price target. To see the full list of analyst forecasts on Rocket Lab USA stock, see the RKLB Stock Forecast page.
Rocket Lab announced its third-quarter 2025 financial results, reporting a record quarterly revenue of $155 million, marking a 48% year-on-year growth. The company highlighted significant achievements including securing 17 Electron launch contracts, launching two HASTE missions, and acquiring Geost to enhance its capabilities in U.S. national security. Rocket Lab also opened Launch Complex 3 for its Neutron rocket and maintains a strong financial position with over $1 billion in liquidity, setting the stage for continued growth and strategic acquisitions.
The most recent analyst rating on (RKLB) stock is a Hold with a $48.00 price target. To see the full list of analyst forecasts on Rocket Lab USA stock, see the RKLB Stock Forecast page.